GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
25 févr. 2021 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
22 févr. 2021 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference
16 févr. 2021 17h35 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
16 févr. 2021 16h03 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today the...
L'étude souligne la valeur clinique potentielle des panels pour l'identification d'hémocultures ePlex®
16 févr. 2021 16h03 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., 16 févr. 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ : GNMK), fournisseur de premier plan en matière de systèmes de tests de diagnostic moléculaire multiplex...
GenMark Diagnostics to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
11 févr. 2021 16h17 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter and full year earnings results after market...
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
11 janv. 2021 16h08 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
28 déc. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
05 nov. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing...
GenMark Diagnostics Reports Third Quarter 2020 Results
28 oct. 2020 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...